These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
453 related articles for article (PubMed ID: 18032857)
1. An open randomized comparative study to test the efficacy and safety of oral terbinafine pulse as a monotherapy and in combination with topical ciclopirox olamine 8% or topical amorolfine hydrochloride 5% in the treatment of onychomycosis. Jaiswal A; Sharma RP; Garg AP Indian J Dermatol Venereol Leprol; 2007; 73(6):393-6. PubMed ID: 18032857 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of topical resin lacquer, amorolfine and oral terbinafine for treating toenail onychomycosis: a prospective, randomized, controlled, investigator-blinded, parallel-group clinical trial. Auvinen T; Tiihonen R; Soini M; Wangel M; Sipponen A; Jokinen JJ Br J Dermatol; 2015 Oct; 173(4):940-8. PubMed ID: 26036329 [TBL] [Abstract][Full Text] [Related]
3. Pharmacoeconomic analysis of ciclopirox nail lacquer solution 8% and the new oral antifungal agents used to treat dermatophyte toe onychomycosis in the United States. Gupta AK J Am Acad Dermatol; 2000 Oct; 43(4 Suppl):S81-95. PubMed ID: 11051137 [TBL] [Abstract][Full Text] [Related]
4. Topical amorolfine for 15 months combined with 12 weeks of oral terbinafine, a cost-effective treatment for onychomycosis. Baran R Br J Dermatol; 2001 Oct; 145 Suppl 60():15-9. PubMed ID: 11777260 [TBL] [Abstract][Full Text] [Related]
5. A multicentre, randomized, controlled study of the efficacy, safety and cost-effectiveness of a combination therapy with amorolfine nail lacquer and oral terbinafine compared with oral terbinafine alone for the treatment of onychomycosis with matrix involvement. Baran R; Sigurgeirsson B; de Berker D; Kaufmann R; Lecha M; Faergemann J; Kerrouche N; Sidou F Br J Dermatol; 2007 Jul; 157(1):149-57. PubMed ID: 17553051 [TBL] [Abstract][Full Text] [Related]
6. An open randomized comparative study of oral itraconazole pulse and terbinafine pulse in the treatment of onychomycosis. Mishra M; Panda P; Tripathy S; Sengupta S; Mishra K Indian J Dermatol Venereol Leprol; 2005; 71(4):262-6. PubMed ID: 16394436 [TBL] [Abstract][Full Text] [Related]
7. Combination of oral terbinafine and topical ciclopirox compared to oral terbinafine for the treatment of onychomycosis. Avner S; Nir N; Henri T J Dermatolog Treat; 2005; 16(5-6):327-30. PubMed ID: 16428154 [TBL] [Abstract][Full Text] [Related]
9. Sporicidal effect of amorolfine and other antimycotics used in the therapy of fungal nail infections. Seidl HP; Jäckel A; Müller J; Schaller M; Borelli C; Polak A Mycoses; 2015 Oct; 58(10):610-9. PubMed ID: 26334024 [TBL] [Abstract][Full Text] [Related]
10. Single-blind, randomized, prospective study on terbinafine and itraconazole for treatment of dermatophyte toenail onychomycosis in the elderly. Gupta AK; Konnikov N; Lynde CW J Am Acad Dermatol; 2001 Mar; 44(3):479-84. PubMed ID: 11209118 [TBL] [Abstract][Full Text] [Related]
11. Treatment of dermatophyte toenail onychomycosis in the United States. A pharmacoeconomic analysis. Gupta AK J Am Podiatr Med Assoc; 2002 May; 92(5):272-86. PubMed ID: 12015408 [TBL] [Abstract][Full Text] [Related]
12. A randomized trial of amorolfine 5% solution nail lacquer combined with oral terbinafine compared with terbinafine alone in the treatment of dermatophytic toenail onychomycoses affecting the matrix region. Baran R; Feuilhade M; Combernale P; Datry A; Goettmann S; Pietrini P; Viguie C; Badillet G; Larnier C; Czernielewski J Br J Dermatol; 2000 Jun; 142(6):1177-83. PubMed ID: 10848743 [TBL] [Abstract][Full Text] [Related]
13. A randomized trial of amorolfine 5% solution nail lacquer in association with itraconazole pulse therapy compared with itraconazole alone in the treatment of Candida fingernail onychomycosis. Rigopoulos D; Katoulis AC; Ioannides D; Georgala S; Kalogeromitros D; Bolbasis I; Karistinou A; Christofidou E; Polydorou D; Balkou P; Fragouli E; Katsambas AD Br J Dermatol; 2003 Jul; 149(1):151-6. PubMed ID: 12890209 [TBL] [Abstract][Full Text] [Related]
14. Ciclopirox nail lacquer topical solution 8% in the treatment of toenail onychomycosis. Gupta AK; Fleckman P; Baran R J Am Acad Dermatol; 2000 Oct; 43(4 Suppl):S70-80. PubMed ID: 11051136 [TBL] [Abstract][Full Text] [Related]
15. Combination of pulse therapy with terbinafine tablets and topical terbinafine cream for the treatment of dermatophyte onychomycosis: a pilot study. Nakano N; Hiruma M; Shiraki Y; Chen X; Porgpermdee S; Ikeda S J Dermatol; 2006 Nov; 33(11):753-8. PubMed ID: 17073989 [TBL] [Abstract][Full Text] [Related]
16. Activity of amorolfine or ciclopirox in combination with terbinafine against pathogenic fungi in onychomycosis-Results of an in vitro investigation. Schaller M; Walker B; Nabhani S; Odon A; Riel S; Jäckel A Mycoses; 2024 Mar; 67(3):e13710. PubMed ID: 38414346 [TBL] [Abstract][Full Text] [Related]
17. Fusarium onychomycosis: prevalence, clinical presentations, response to itraconazole and terbinafine pulse therapy, and 1-year follow-up in nine cases. Ranawaka RR; Nagahawatte A; Gunasekara TA Int J Dermatol; 2015 Nov; 54(11):1275-82. PubMed ID: 26223159 [TBL] [Abstract][Full Text] [Related]
18. Economic analysis of oral and topical therapies for onychomycosis of the toenails and fingernails. Casciano J; Amaya K; Doyle J; Arikian S; Shear N; Haspel M; Kahler K Manag Care; 2003 Mar; 12(3):47-54. PubMed ID: 12685377 [TBL] [Abstract][Full Text] [Related]
19. A multicentre, randomised, parallel-group, double-blind, vehicle-controlled and open-label, active-controlled study (versus amorolfine 5%), to evaluate the efficacy and safety of terbinafine 10% nail lacquer in the treatment of onychomycosis. Blume-Peytavi U; Tosti A; Falqués M; Tamarit ML; Carreño C; Galván J; Tebbs V Mycoses; 2022 Apr; 65(4):392-401. PubMed ID: 34752667 [TBL] [Abstract][Full Text] [Related]
20. Randomized, double-blind, comparative study on efficacy and safety of itraconazole pulse therapy and terbinafine pulse therapy on nondermatophyte mold onychomycosis: A study with 90 patients. Ranawaka RR; Nagahawatte A; Gunasekara TA; Weerakoon HS; de Silva SH J Dermatolog Treat; 2016 Aug; 27(4):364-72. PubMed ID: 26651495 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]